PETMED EXPRESS INC (PETS) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 465 transactions totaling $65.6M, demonstrating a bearish sentiment with -$63.0M in net insider flow. The most recent transaction on Jan 21, 2026 involved a transaction of 26,057 shares valued at $0.
No significant insider buying has been recorded for PETS in the recent period.
No significant insider selling has been recorded for PETS in the recent period.
Based on recent SEC filings, insider sentiment for PETS is bearish with an Insider Alignment Score of 2/100 and a net flow of -$63.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PETMED EXPRESS INC (PETS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading PETS stock, having executed 465 transactions in the past 90 days. The most active insider is Menderes Akdag (Executive), who has made 69 transactions totaling $32.1M.
Get notified when executives and directors at PETS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Fulgoni Gian | Executive | Disposition | 26,057 | $N/A | $0 | |
| Oct 30, 2025 | Batushansky Peter | Executive | Award | 33,846 | $N/A | $0 | |
| Oct 30, 2025 | Solivan Leah | Executive | Award | 33,846 | $N/A | $0 | |
| Oct 30, 2025 | L. Mennen Justin | Executive | Award | 33,846 | $N/A | $0 | |
| Oct 30, 2025 | Lacamp James | Executive | Award | 34,866 | $N/A | $0 | |
| Oct 30, 2025 | Krulik Douglas | Executive | Award | 20,000 | $N/A | $0 | |
| Oct 30, 2025 | Fulgoni Gian | Executive | Award | 33,846 | $N/A | $0 | |
| Sep 9, 2025 | Krulik Douglas | Executive | Award | 10,000 | $N/A | $0 | |
| Aug 13, 2025 | Ltd Silvercape Investments | Executive | Purchase | 101,000 | $3.17 | $320.2K | |
| Aug 1, 2025 | Ltd Silvercape Investments | Executive | Purchase | 118,200 | $3.21 | $379.4K | |
| Jul 18, 2025 | Ltd Silvercape Investments | Executive | Purchase | 17,565 | $3.23 | $56.7K | |
| Jul 17, 2025 | Ltd Silvercape Investments | Executive | Purchase | 31,701 | $3.15 | $99.9K | |
| Jul 2, 2025 | Ltd Silvercape Investments | Executive | Purchase | 2,817 | $3.22 | $9.1K | |
| Jul 1, 2025 | Ltd Silvercape Investments | Executive | Purchase | 694 | $3.21 | $2.2K | |
| Sep 27, 2024 | M. D'elia Robyn | Executive | Award | 250,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 248 | $64.3M | 67.7% |
Award(A) | 124 | $24.2M | 25.4% |
Exercise (Options)(X) | 77 | $5.0M | 5.3% |
Purchase(P) | 9 | $1.3M | 1.4% |
Disposition(D) | 5 | $170.2K | 0.2% |
Other(J) | 2 | $52.5K | 0.1% |
Insider selling pressure at PETMED EXPRESS INC has increased, with 28 insiders executing 465 transactions across all time. Total sales of $64.3M significantly outpace purchases of $1.3M, resulting in a net outflow of $63.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.